Dermatitis
📧 Sign up to get email alerts when something new happens for Dermatitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-02-11FDA Approved: HYDROCORTISONE VALERATE — Original Application (Cosette Pharmaceuticals, Inc.)
The FDA approved Cosette Pharmaceuticals' original application for hydrocortisone valerate, a generic topical corticosteroid for inflammator…
-
FDA approval · 2021-02-05FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approves a generic Triamcinolone Acetonide topical product under an Original Application (ANDA) for Padagis Israel Pharmaceuticals Ltd.
-
FDA approval · 2020-09-02FDA Approved: PREDNISONE — Original Application (Strides Pharma Science Limited)
FDA approval of a generic prednisone (PREDNISONE) Original Application by Strides Pharma Science Limited.
-
FDA approval · 2020-08-24FDA Approved: DESONIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals' desonide product under an Original Application, making a generic desonide topical product available. D…
-
FDA approval · 2020-07-06FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma's supplemental approval for the clotrimazole and betamethasone dipropionate topical product. The action approves…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-06-17FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's original application for Betamethasone Dipropionate topical, a potent corticosteroid for inflammatory …
-
FDA approval · 2020-06-15FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
The FDA approved a supplemental application for Betamethasone Dipropionate from E. Fougera & Co., indicating an approval related to the gene…
-
FDA approval · 2020-06-09FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Betamethasone Dipropionate by Actavis Pharma, Inc., indicating an update to the product's approv…
-
FDA approval · 2020-06-01FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Strides Pharma Science Limited)
FDA approved Strides Pharma Science Limited's Triamcinolone acetonide via an Original Application (ANDA) for a generic formulation.
-
FDA approval · 2020-03-04FDA Approved: HYDROCORTISONE VALERATE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved the original application for hydrocortisone valerate by Cosette Pharmaceuticals, Inc., establishing a new generic topical corti…
-
FDA approval · 2020-02-10FDA Approved: FLUOCINONIDE — Original Application (Zydus Lifesciences Limited)
The FDA approved the original application for a generic fluocinolone topical product from Zydus Lifesciences Limited. The approval confirms …
-
FDA approval · 2020-01-27FDA Approved: CLOBETASOL PROPIONATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's generic clobetasol propionate topical product under an original application, expanding access…
-
FDA approval · 2019-12-18FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved an original application for Betamethasone dipropionate by Lupin Pharmaceuticals, Inc., granting a generic topical corticosteroi…
-
FDA approval · 2019-11-29FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Encube Ethicals, Inc.)
The FDA approved Encube Ethicals' Triamcinolone Acetonide Ointment USP, 0.05% as an original generic topical corticosteroid product through …
-
FDA approval · 2019-11-26FDA Approved: FLUOCINONIDE — Original Application (Xiromed LLC)
FDA approved the original application for fluocinonide (topical corticosteroid) submitted by Xiromed LLC.
-
FDA approval · 2019-11-15FDA Approved: CLOBETASOL PROPIONATE — Original Application (Encube Ethicals, Inc.)
FDA approved the Original Application for Clobetasol Propionate Ointment USP, 0.05% (generic) by Encube Ethicals, Inc.
-
FDA approval · 2019-10-23FDA Approved: DESONIDE — Original Application (Alembic Pharmaceuticals Inc.)
The FDA approved an original ANDA for desonide from Alembic Pharmaceuticals Inc., enabling the sale of generic desonide products.
-
FDA approval · 2019-10-21FDA Approved: CLOBETASOL PROPIONATE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals' original ANDA for clobetasol propionate topical.
-
FDA approval · 2019-10-02FDA Approved: CLOBETASOL PROPIONATE — Original Application (Micro Labs Limited)
The FDA approved Micro Labs Limited's original application for clobetasol propionate topical, a potent corticosteroid, for inflammatory and …
-
FDA approval · 2019-09-24FDA Approved: CLOBETASOL PROPIONATE — Original Application (Zydus Lifesciences Limited)
FDA approves the original application for clobetasol propionate topical (generic) by Zydus Lifesciences Limited, adding another generic opti…
-
FDA approval · 2019-09-06FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for clobetasol propionate from Sun Pharmaceutical Industries under an ANDA.
-
FDA approval · 2019-09-06FDA Approved: CLOBETASOL PROPIONATE EMOLLIENT FORMULATION — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for a clobetasol propionate emollient formulation from Padagis Israel Pharmaceuticals Ltd, granting …
-
FDA approval · 2019-02-21FDA Approved: PREDNISONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for prednisone from Mylan Pharmaceuticals, indicating approval of an existing generic product's …
-
FDA approval · 2019-01-30FDA Approved: DESONIDE OINTMENT, 0.05% — Original Application (Encube Ethicals, Inc.)
FDA approved Desonide Ointment 0.05% as a generic topical corticosteroid for relief of inflammatory and pruritic skin conditions; indicated …
-
FDA approval · 2018-12-26FDA Approved: CLOBETASOL PROPIONATE — Original Application (AvKARE)
FDA approved AvKARE's original ANDA for clobetasol propionate topical product (generic).